GAP

(Gemcitabine Abraxane Pancreas) trial

A PHASE II RANDOMIZED TRIAL COMPARING A COMBINATION OF ABRAXANE AND GEMCITABINE VERSUS GEMCITABINE ALONE AS FIRST LINE TREATMENT IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER

· Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer e A GISCAD phase II randomized trial

Scarica il file